Ondansetron's Opposite Effect on Postoperative Analgesia of Acetaminophen (OOEOPAOA)
Primary Purpose
Postoperative Pain
Status
Completed
Phase
Phase 4
Locations
Turkey
Study Type
Interventional
Intervention
ondansetron
isotonic
Sponsored by
About this trial
This is an interventional treatment trial for Postoperative Pain focused on measuring Acetaminophen, ondansetron
Eligibility Criteria
Inclusion Criteria:
- Patients 18-80 years old scheduled for hysterectomy
- Horizontal or vertical abdominal skin incision
- Ability to operate a patient-controlled analgesia (PCA) device
- Written informed consent.
Exclusion Criteria:
- Emergency or urgent procedures
- Women with pre-existing chronic pain at any site requiring opioid analgesia
- Who had a history of significant Axis I psychiatric disease (major depressive disorder, bipolar disorder, schizophrenia, etc.)
- Significant hepatic (alanine aminotransferase or aspartate aminotransferase >2 times normal) or renal (serum creatinine >2 mg/dl) impairment
- Allergy to ondansetron or acetaminophen
- Were pregnant
Sites / Locations
- Mustafa Kemal University Medicine Faculty
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Placebo Comparator
Arm Label
ondansetron
isotonic
Arm Description
ondansetron iv, 8 mg, skin closure time
isotonic 2ml, once, skin closure time
Outcomes
Primary Outcome Measures
Postoperative pain
Visual analogue scale
Opioid (tramadol) consumption
Tramadol consumption
Secondary Outcome Measures
Postoperative complications
Full Information
NCT ID
NCT02296333
First Posted
August 24, 2014
Last Updated
March 12, 2015
Sponsor
Mustafa Kemal University
1. Study Identification
Unique Protocol Identification Number
NCT02296333
Brief Title
Ondansetron's Opposite Effect on Postoperative Analgesia of Acetaminophen
Acronym
OOEOPAOA
Official Title
Double Blinded Study Ondansetron's Opposite Effect on Postoperative Analgesia of Acetaminophen
Study Type
Interventional
2. Study Status
Record Verification Date
March 2015
Overall Recruitment Status
Completed
Study Start Date
May 2014 (undefined)
Primary Completion Date
November 2014 (Actual)
Study Completion Date
December 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Mustafa Kemal University
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of the study is to determine whether the effect of ondansetron on the analgesic effect of acetaminophen. Because 5HT3 blockers prevent the analgesic effects of acetaminophen and also reduce opioid consumption
Detailed Description
The investigators enrolled 80 American Society of Anesthesiologists Physical Status I-II women 18-80 years old scheduled for hysterectomy under general anesthesia over the course of a year. The study will be restricted hysterectomies with horizontal abdominal skin incision who will be able to operate a patient-controlled analgesia (PCA) device.
Participating women will be premedicated with 1-2 mg intravenous (IV) midazolam per preference of the attending anesthesiologist.
Anesthesia will be induced with propofol (2 mg/kg IV); intubation will be facilitated by rocuronium (0.6 mg/kg IV); and anesthesia will be maintained by sevoflurane in combination with nitrous oxide 50% in oxygen. Fentanyl, 2 µg/kg intravenous will be given 3-5 min before the surgical incision.
After endotracheal intubation, all patients' lungs will be mechanically ventilated to maintain the end-expiratory carbon dioxide values between 34 and 36 mmHg.
A Pfannenstiel approach will be used in each woman, and the same surgeon will be conducted all operations.
Randomization will be web-based and out of the control of any investigator. The web system will be accessed by the anesthesia resident at the induction. Drugs will be covered by opaque plastic to keep the surgical team and anesthesiologists blinded to treatment.
Both groups patients will be received 1 g acetaminophen in 100 ml saline given every 6 hours starting with the skin closure for 24 hours, an amount generally regarded as safe.
Group I patients will be received '8 mg ondansetron hydrochloride'
Group II patients will be received '2 ml saline' Both of them will be applied in a 100 ml saline bag at the same time with the skin closure.
After return of spontaneous ventilation and tracheal extubation, patients will be transferred to the post anesthesia care unit (PACU).
Patients were connected to a patient-controlled analgesia (PCA) device and postoperative analgesia will be provided using 20-mg intravenous bolus injections of tramadol at a lockout interval of 15 min and with a maximum 4-h limit of 150 mg. The PCA device will be discontinued when the patient made no demands for the opioid analgesic in the preceding 4-h interval or at a maximum of 24 hours after surgery.
heart rate
systolic arterial blood pressures
diastolic arterial blood pressures
mean arterial blood pressures
oxygen saturation
respiratory rate
visual analogue scales while sitting and laying
tramadol consumption
additive analgesics
complications
postoperative nausea and vomiting scores
antiemetic use will be assessed at PACU, 1th. hour, 4th hour, 8th hour, 12th hour, 16th hour, 20th hour and 24th hour.
Pain satisfaction scale
ambulation time
first flatus time
oral intake time
Hospital anxiety and depression scale
When pain scores were VAS ≥5, then as a rescue analgesics 75 mg diclofenac Na intramuscularly will be given. If systolic arterial pressure (SAP) will be <90 mmHg or mean arterial pressure will be <50 mmHg, 5 mg intravenous ephedrine HCl will be given. If the heart rate will be <50 beats/minute, 0.5 mg atropine sulfate intravenous will be given. When patients sustained nausea or vomiting lasting longer than 5 minutes, metoclopramide (10 mg intravenously) will be given.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Postoperative Pain
Keywords
Acetaminophen, ondansetron
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Care ProviderInvestigator
Allocation
Randomized
Enrollment
80 (Actual)
8. Arms, Groups, and Interventions
Arm Title
ondansetron
Arm Type
Active Comparator
Arm Description
ondansetron iv, 8 mg, skin closure time
Arm Title
isotonic
Arm Type
Placebo Comparator
Arm Description
isotonic 2ml, once, skin closure time
Intervention Type
Drug
Intervention Name(s)
ondansetron
Other Intervention Name(s)
Zofran
Intervention Description
8 mg intravenous in the skin closure
Intervention Type
Drug
Intervention Name(s)
isotonic
Intervention Description
8 mg intravenous in the skin closure
Primary Outcome Measure Information:
Title
Postoperative pain
Description
Visual analogue scale
Time Frame
Postoperative 24 hours
Title
Opioid (tramadol) consumption
Description
Tramadol consumption
Time Frame
Postoperative 24 hours
Secondary Outcome Measure Information:
Title
Postoperative complications
Time Frame
Postoperative 24 hours
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients 18-80 years old scheduled for hysterectomy
Horizontal or vertical abdominal skin incision
Ability to operate a patient-controlled analgesia (PCA) device
Written informed consent.
Exclusion Criteria:
Emergency or urgent procedures
Women with pre-existing chronic pain at any site requiring opioid analgesia
Who had a history of significant Axis I psychiatric disease (major depressive disorder, bipolar disorder, schizophrenia, etc.)
Significant hepatic (alanine aminotransferase or aspartate aminotransferase >2 times normal) or renal (serum creatinine >2 mg/dl) impairment
Allergy to ondansetron or acetaminophen
Were pregnant
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Onur Koyuncu, Ass.prof
Organizational Affiliation
Mustafa Kemal University Medicine Faculty
Official's Role
Study Chair
Facility Information:
Facility Name
Mustafa Kemal University Medicine Faculty
City
Hatay
ZIP/Postal Code
31030
Country
Turkey
12. IPD Sharing Statement
Citations:
PubMed Identifier
1904822
Citation
Tjolsen A, Lund A, Hole K. Antinociceptive effect of paracetamol in rats is partly dependent on spinal serotonergic systems. Eur J Pharmacol. 1991 Feb 7;193(2):193-201. doi: 10.1016/0014-2999(91)90036-p.
Results Reference
result
PubMed Identifier
16580905
Citation
Pickering G, Loriot MA, Libert F, Eschalier A, Beaune P, Dubray C. Analgesic effect of acetaminophen in humans: first evidence of a central serotonergic mechanism. Clin Pharmacol Ther. 2006 Apr;79(4):371-8. doi: 10.1016/j.clpt.2005.12.307.
Results Reference
result
PubMed Identifier
20220746
Citation
Jokela R, Ahonen J, Seitsonen E, Marjakangas P, Korttila K. The influence of ondansetron on the analgesic effect of acetaminophen after laparoscopic hysterectomy. Clin Pharmacol Ther. 2010 Jun;87(6):672-8. doi: 10.1038/clpt.2009.281. Epub 2010 Mar 10.
Results Reference
result
Links:
URL
http://www.ncbi.nlm.nih.gov/pubmed/20220746
Description
http://www.ncbi.nlm.nih.gov/pubmed/20220746
Learn more about this trial
Ondansetron's Opposite Effect on Postoperative Analgesia of Acetaminophen
We'll reach out to this number within 24 hrs